steady-state interaction encainide quinidine patients arrhythmias pharmacokinetic pharmacodynamic interaction quinidine single doses encainide healthy volunteers subjects extensive metabolizer phenotype quinidine encainide-induced QRS prolongation marker sodium channel block encainide biotransformation potent active metabolites O-desmethyl encainide ODE encainide purpose study hypothesis quinidine sodium channel block inference arrhythmia suppression encainide therapy patients extensive metabolizer phenotype extensive metabolizer patients extent QRS prolongation chronic encainide therapy quinidine msec arrhythmia suppression Plasma concentration data encainide metabolism ODE quinidine subsequent encainide formation ODE steady-state plasma ODE unchanged whereas plasma ng/ml contrast changes disposition pharmacodynamics poor metabolizers effect drug interaction patients differential sensitivities inhibition quinidine encainide O-demethylation subsequent ODE Evaluation potential drug interactions assessment possible genetic factors steady-state effects 